Is it ethical to still prescribe conventionally-fractionated treatments for breast cancer, prostate cancer, and osseous metastatic disease for patients that do not have contraindications to hypofractionation?
What do you consider valid reasons to deliver 39 or more fractions for prostate cancers, 25 or more fractions for breast cancers or 10 or more fractions for bone metastases?
I learn a lot from reading others' thoughts. Dr. @...
👏👏👏